OTS 2026: Advancing the Future of Oligonucleotide Therapeutics
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting 2026 brings together leading researchers, clinicians, biotech innovators, and pharmaceutical companies to explore the latest advances in oligonucleotide-based medicines. Taking place in Denver, Colorado, the conference serves as a premier forum for discussing breakthroughs in RNA therapeutics, gene silencing technologies, delivery systems, and nucleic acid drug development. With a strong emphasis on scientific innovation and translational research, OTS provides an invaluable opportunity for collaboration, networking, and knowledge sharing across the rapidly evolving oligonucleotide therapeutics landscape.
View Event
